KTC
PCRX icon

Kistler-Tiffany Companies’s Pacira BioSciences PCRX Stock Holding History

Kistler-Tiffany Companies’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-130
Closed -$5K – 619
2015
Q3 		$5K Hold
130
– – ﹤0.01% 500
2015
Q2 		$9K Hold
130
– – 0.01% 465
2015
Q1 		$12K Hold
130
– – 0.01% 424
2014
Q4 		$12K Hold
130
– – 0.01% 421
2014
Q3 		$13K Hold
130
– – 0.01% 419
2014
Q2 		$12K Hold
130
– – 0.01% 416
2014
Q1 		$9K Hold
130
– – 0.01% 437
2013
Q4 		$7K Hold
130
– – 0.01% 470
2013
Q3 		$6K Buy
+130
New +$4.74K ﹤0.01% 479

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kistler-Tiffany Companies's PCRX Position: Q4 2015 in Review

Kistler-Tiffany Companies sold out of Pacira BioSciences (PCRX) in Q4 2015, closing a stake of 130 shares — an estimated $5K sold.

Kistler-Tiffany Companies first reported a position in PCRX in Q3 2013 and held it in 9 quarters. The position peaked at $13K in Q3 2014. 214 funds tracked by Wall St. Rank hold PCRX as of Q4 2015.

  • Kistler-Tiffany Companies reported no remaining Pacira BioSciences position as of Q4 2015 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 130 Pacira BioSciences shares in Q4 2015, an estimated $5K.
  • Kistler-Tiffany Companies first reported a position in Pacira BioSciences in Q3 2013 and held it in 9 quarters.
  • Kistler-Tiffany Companies's Pacira BioSciences position peaked at $13K in Q3 2014.
  • 214 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2015.

Based on Kistler-Tiffany Companies's 13F filing for Q4 2015, filed 6 Jan 2016.